查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542526

全球 AAV 合约开发和製造组织市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global AAV Contract Development And Manufacturing Organizations Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

全球 AAV 合约开发和製造组织市场需求预计将从 2023 年的 6.8398 亿美元达到近 29.9921 亿美元的市场规模，2024 年至 2032 年研究期间的复合年增长率为 17.85%。

AAV（腺相关病毒）合约开发和製造组织 (CDMO) 是专门从事基于 AAV 的基因疗法的开发、製造和测试的公司。 AAV 是一种小型非致病性病毒，通常用作基因治疗中基因传递的载体。 AAV CDMO 与客户合作，针对特定治疗应用设计和优化 AAV 载体。他们还提供 AAV 载体的生产服务，包括细胞系的开发、载体生产过程的最佳化以及最终产品的纯化和表征。此外，AAV CDMO 对 AAV 载体进行严格的测试，以确保安全性和有效性，包括效力、纯度、无菌和身份测试。

市场动态

随着越来越多的基因治疗产品被批准用于临床，基因治疗市场正在迅速扩大。 AAV 载体是基因治疗递送的热门选择，对基因治疗的需求不断增长正在推动 AAV CDMO 市场的成长。 AAV 载体技术的进步改进了载体生产流程、提高了转导效率并减少了免疫反应。这些进步使 AAV 载体对基因疗法应用更具吸引力，并增加了对 AAV CDMO 服务的需求。近年来，基因治疗研究的资金供应大幅增加，政府机构、私人投资者和非营利组织都为基因治疗市场的成长做出了贡献。这笔资金正在推动新基因疗法的开发，进而增加对 AAV CDMO 服务的需求。 FDA 等监管机构已表示支持基因疗法的开发，并实施了基因疗法产品的快速批准途径。这种监管支持有助于推动基因治疗市场的成长，包括 AAV CDMO 市场。许多生技和製药公司选择将基因治疗製造外包给专门的 CDMO，而不是投资昂贵的内部设施。这一趋势导致对 AAV CDMO 服务的需求不断增加，因为这些公司正在寻找经验丰富的合作伙伴来帮助他们开发和製造基因疗法产品。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对 AAV 合约开发和製造组织全球市场的每个细分市场进行包容性评估。 AAV 合约开发和製造组织行业的成长和趋势为本研究提供了整体方法。

市场区隔

AAV 合约开发和製造组织市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按工作流程

  • 上游处理（向量放大和扩展、向量恢復和收穫）
  • 下游加工（纯化、填充完成）

依文化类型

  • 依附文化
  • 悬浮文化

按申请

  • 细胞与基因疗法开发
  • 疫苗开发
  • 生物製药与药物发现
  • 生物医学研究

按最终用户

  • 製药及生物製药公司
  • 学术及研究机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的 AAV 合约开发和製造组织市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 AAV 合约开发和製造组织市场的主要参与者包括 Thermo Fischer Scientific Inc.、Creative Biogene、Catalent Inc.、Charles River Laboratories International Inc.、Danaher (Aldevron)、Forge Biologics、Genezen、ViroCell Biologics、Merck KGaA、Viralgen 、 Biovian Oy、Esco Lifesciences (Esco Aster Pte. Ltd.)、GenScript ProBio、Porton Advanced Solution Ltd、Ask Bio、Showa Denko、Takara Bio Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如作为关键的併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：AAV 合约开发与製造组织 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 依工作流程进行市场吸引力分析
    • 按文化类型进行的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球 AAV 合约开发与製造组织市场分析：按工作流程

  • 按工作流程概述
  • 历史和预测数据
  • 按工作流程分析
  • 上游处理（向量放大和扩展、向量恢復和收穫）
  • 下游加工（纯化、填充完成）

第 6 章：全球 AAV 合约开发与製造组织市场分析：按文化类型

  • 按文化类型概述
  • 历史和预测数据
  • 按文化类型分析
  • 依附文化
  • 悬浮文化

第 7 章：全球 AAV 合约开发与製造组织市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 细胞与基因疗法开发
  • 疫苗开发
  • 生物製药与药物发现
  • 生物医学研究

第 8 章：全球 AAV 合约开发与製造组织市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 製药及生物製药公司
  • 学术及研究机构

第 9 章：全球 AAV 合约开发与製造组织市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：AAV 合约开发与製造组织公司的竞争格局

  • AAV 合约开发和製造组织市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Thermo Fischer Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Creative Biogene
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Catalent Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Charles River Laboratories International Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher (Aldevron)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Forge Biologics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Genezen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ViroCell Biologics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Viralgen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Biovian Oy
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Esco Lifesciences (Esco Aster Pte. Ltd.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GenScript ProBio
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Porton Advanced Solution Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ask Bio
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Showa Denko
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Takara Bio Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112110635

The global demand for AAV Contract Development And Manufacturing Organizations Market is presumed to reach the market size of nearly USD 2999.21 Million by 2032 from USD 683.98 Million in 2023 with a CAGR of 17.85% under the study period 2024 - 2032.

AAV (adeno-associated virus) Contract Development and Manufacturing Organizations (CDMOs) are companies that specialize in the development, manufacturing, and testing of AAV-based gene therapies. AAV is a small, non-pathogenic virus that is commonly used as a vector for gene delivery in gene therapy. AAV CDMOs work with clients to design and optimize AAV vectors for specific therapeutic applications. They also provide services for the production of AAV vectors, including the development of cell lines, optimization of vector production processes, and purification and characterization of the final product. In addition, AAV CDMOs conduct rigorous testing of the AAV vectors to ensure safety and efficacy, including tests for potency, purity, sterility, and identity.

MARKET DYNAMICS

The market for gene therapies is expanding rapidly as more gene therapy products are approved for clinical use. AAV vectors are a popular choice for gene therapy delivery, and the increasing demand for gene therapies is driving growth in the AAV CDMO market. Advances in AAV vector technology have led to improved vector production processes, increased transduction efficiency, and reduced immune responses. These advances have made AAV vectors more attractive for gene therapy applications and have increased the demand for AAV CDMO services. The availability of funding for gene therapy research has increased significantly in recent years, with government agencies, private investors, and non-profit organizations all contributing to the gene therapy market growth. This funding is driving the development of new gene therapies, which in turn is increasing demand for AAV CDMO services. Regulatory agencies such as the FDA have shown support for the development of gene therapies and have implemented expedited approval pathways for gene therapy products. This regulatory support is helping to drive growth in the gene therapy market, including the AAV CDMO market. Many biotech and pharma companies are choosing to outsource their gene therapy manufacturing to specialized CDMOs rather than investing in expensive in-house facilities. This trend is increasing demand for AAV CDMO services as these companies seek out experienced partners to help them develop and manufacture their gene therapy products.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of AAV Contract Development And Manufacturing Organizations. The growth and trends of AAV Contract Development And Manufacturing Organizations industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the AAV Contract Development And Manufacturing Organizations market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Workflow

  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting)
  • Downstream Processing (Purification, Fill Finish)

By Culture Type

  • Adherent Culture
  • Suspension Culture

By Application

  • Cell & Gene Therapy Development
  • Vaccine Development
  • Biopharmaceutical & Pharmaceutical Discovery
  • Biomedical Research

By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the AAV Contract Development And Manufacturing Organizations market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the AAV Contract Development And Manufacturing Organizations market include Thermo Fischer Scientific Inc., Creative Biogene, Catalent Inc., Charles River Laboratories International Inc., Danaher (Aldevron), Forge Biologics, Genezen, ViroCell Biologics, Merck KGaA, Viralgen, Biovian Oy, Esco Lifesciences (Esco Aster Pte. Ltd.), GenScript ProBio, Porton Advanced Solution Ltd, Ask Bio, Showa Denko, Takara Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Workflow
    • 3.7.2 Market Attractiveness Analysis By Culture Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY WORKFLOW

  • 5.1. Overview By Workflow
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Workflow
  • 5.4. Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Historic and Forecast Sales By Regions
  • 5.5. Downstream Processing (Purification, Fill Finish) Historic and Forecast Sales By Regions

6. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY CULTURE TYPE

  • 6.1. Overview By Culture Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Culture Type
  • 6.4. Adherent Culture Historic and Forecast Sales By Regions
  • 6.5. Suspension Culture Historic and Forecast Sales By Regions

7. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cell & Gene Therapy Development Historic and Forecast Sales By Regions
  • 7.5. Vaccine Development Historic and Forecast Sales By Regions
  • 7.6. Biopharmaceutical & Pharmaceutical Discovery Historic and Forecast Sales By Regions
  • 7.7. Biomedical Research Historic and Forecast Sales By Regions

8. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-User
  • 8.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.5. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS COMPANIES

  • 10.1. AAV Contract Development And Manufacturing Organizations Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fischer Scientific Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Creative Biogene
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Catalent Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Charles River Laboratories International Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Danaher (Aldevron)
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Forge Biologics
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Genezen
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. ViroCell Biologics
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Merck KGaA
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Viralgen
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Biovian Oy
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Esco Lifesciences (Esco Aster Pte. Ltd.)
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. GenScript ProBio
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Porton Advanced Solution Ltd
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Ask Bio
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Showa Denko
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. Takara Bio Inc
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Workflow (USD MN)
  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales By Geography (USD MN)
  • Downstream Processing (Purification, Fill Finish) Market Sales By Geography (USD MN)
  • Analysis By Culture Type (USD MN)
  • Adherent Culture Market Sales By Geography (USD MN)
  • Suspension Culture Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cell & Gene Therapy Development Market Sales By Geography (USD MN)
  • Vaccine Development Market Sales By Geography (USD MN)
  • Biopharmaceutical & Pharmaceutical Discovery Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global AAV Contract Development And Manufacturing Organizations Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of AAV Contract Development And Manufacturing Organizations Report
  • Market Research Process
  • Market Research Methodology
  • Global AAV Contract Development And Manufacturing Organizations Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Culture Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Workflow (USD MN)
  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales By Geography (USD MN)
  • Downstream Processing (Purification, Fill Finish) Market Sales By Geography (USD MN)
  • Global Market Analysis By Culture Type (USD MN)
  • Adherent Culture Market Sales By Geography (USD MN)
  • Suspension Culture Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cell & Gene Therapy Development Market Sales By Geography (USD MN)
  • Vaccine Development Market Sales By Geography (USD MN)
  • Biopharmaceutical & Pharmaceutical Discovery Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.